ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

(8-page issue)

October 4, 2002

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

April 25, 2008

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984